RecruitingNCT05257954
Frailty in Patient Undergoing Percutaneous Left Atrial Appendage Closure.
Frailty in Patient Undergoing Percutaneous Left Atrial Appendage Closure The Frail-LAAC Study
Sponsor
Josep Rodes-Cabau
Enrollment
500 participants
Start Date
Mar 1, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
To assess the prevalence and severity of frailty in patients undergoing LAAC, as well as its association to peri-procedural and long-term outcomes and quality of life.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Transcatheter LAAC with any approved device
- Age ≥18 years old
Exclusion Criteria2
- Unable to provide informed consent
- Severe neuropsychiatric impairment
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05257954
Related Trials
Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation
NCT074413821 location
Prehabilitation for Ovarian Cancer Patients
NCT053648791 location
Ultrasound, Nutritional Status, and Outcomes in Surgical ICU
NCT074757671 location
The Impact of Geriatric Assessment on the Treatment Plan of Elderly Patients With T2DM
NCT064694371 location
Investigating the Combined Effects of Protein, Blueberries, and Exercise on Cardiovascular Health and Frailty in Older Nova Scotians
NCT066932711 location